{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:42:58Z","timestamp":1789191778109,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.parkreldis.2008.03.003","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T14:44:01Z","timestamp":1210085041000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Octarepeat changes of prion protein in Parkinson's disease"],"prefix":"10.1016","volume":"15","author":[{"given":"Vinchi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Chao","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Wen","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Din-E.","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ching","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2008.03.003_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.21022","article-title":"Genetics of Parkinson's disease and parkinsonism","volume":"60","author":"Hardy","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa033277","article-title":"Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews","volume":"351","author":"Aharon-Peretz","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib3","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1523\/JNEUROSCI.21-21-08447.2001","article-title":"Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease","volume":"21","author":"Le","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0169-328X(02)00586-7","article-title":"Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease","volume":"10","author":"Yoo","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib5","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/brain\/awh625","article-title":"A possible role for humoral immunity in the pathogenesis of Parkinson's disease","volume":"128","author":"Orr","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1023\/B:NERE.0000013736.80749.4b","article-title":"Effects of the combined treatment of naloxone and indomethacin on catecholamines and behavior after intranigral lipopolysaccharide injection","volume":"29","author":"Wang","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1073\/pnas.0237313100","article-title":"Unique inflammatory RNA profiles of microglia in Creutzfeldt\u2013Jakob disease","volume":"100","author":"Baker","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbrc.2005.05.091","article-title":"Nitric oxide induces prion protein via MEK and p38 MAPK signaling","volume":"333","author":"Wang","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/1531-8249(200005)47:5<575::AID-ANA4>3.0.CO;2-W","article-title":"Diagnosis of new variant Creutzfeldt\u2013Jakob disease","volume":"47","author":"Will","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.WNL.0000130198.72589.69","article-title":"Prion protein codon 129 polymorphism and risk of Alzheimer disease","volume":"63","author":"Riemenschneider","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.1439789","article-title":"Fatal familial insomnia and familial Creutzfeldt\u2013Jakob disease: disease phenotype determined by a DNA polymorphism","volume":"258","author":"Goldfarb","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib12","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1212\/01.WNL.0000096940.92986.02","article-title":"Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant","volume":"61","author":"Walz","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib13","doi-asserted-by":"crossref","first-page":"13760","DOI":"10.1021\/bi001472t","article-title":"Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy","volume":"39","author":"Aronoff-Spencer","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbrc.2004.11.092","article-title":"Octapeptide repeat region and N-terminal half of hydrophobic region of prion protein (PrP) mediate PrP-dependent activation of superoxide dismutase","volume":"326","author":"Sakudo","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib15","doi-asserted-by":"crossref","first-page":"10926","DOI":"10.1073\/pnas.88.23.10926","article-title":"Transmissible familial Creutzfeldt\u2013Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene","volume":"88","author":"Goldfarb","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10654-007-9112-7","article-title":"Polymorphism distribution of prion protein codon 117, 129 and 171 in Taiwan","volume":"22","author":"Wang","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neulet.2005.10.081","article-title":"The human prion gene M129V polymorphism is not associated with idiopathic Parkinson's disease in three distinct populations","volume":"395","author":"Scholz","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.neurobiolaging.2005.05.025","article-title":"Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis","volume":"27","author":"Del Bo","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00702-005-0329-x","article-title":"Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease","volume":"13","author":"Gossrau","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib20","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1126\/science.1103932","article-title":"Human prion protein with valine 129 prevents expression of variant CJD phenotype","volume":"306","author":"Wadsworth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib21","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/brain\/awh249","article-title":"Predictors of survival in sporadic Creutzfeldt\u2013Jakob disease and other human transmissible spongiform encephalopathies","volume":"127","author":"Pocchiari","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib23","doi-asserted-by":"crossref","first-page":"31390","DOI":"10.1074\/jbc.M401754200","article-title":"Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt\u2013Jakob disease","volume":"279","author":"Tahiri-Alaoui","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib24","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1096\/fj.06-7522com","article-title":"Functional relevance of DNA polymorphisms within the promoter region of the prion protein gene and their association to BSE infection","volume":"21","author":"Kashkevich","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib25","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1093\/nar\/29.12.2581","article-title":"Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions","volume":"29","author":"Thanaraj","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.274.5289.1005","article-title":"U1-mediated exon definition interactions between AT-AC and GT-AG introns","volume":"274","author":"Wu","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib27","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1021\/bi050251q","article-title":"Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils","volume":"44","author":"Bocharova","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.freeradbiomed.2006.09.019","article-title":"Prion protein does not redox-silence Cu2+, but is a sacrificial quencher of hydroxyl radicals","volume":"42","author":"Nadal","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10038-004-0150-7","article-title":"Polymorphisms of the prion protein gene (PRNP) in a Korean population","volume":"49","author":"Jeong","year":"2004","journal-title":"J Hum Genet"},{"key":"10.1016\/j.parkreldis.2008.03.003_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1212\/WNL.44.2.291","article-title":"Iatrogenic Creutzfeldt\u2013Jakob disease: an example of the interplay between ancient genes and modern medicine","volume":"44","author":"Brown","year":"1994","journal-title":"Neurology"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802008000990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802008000990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:11:00Z","timestamp":1761178260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802008000990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1353802008000990"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2008.03.003","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Octarepeat changes of prion protein in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2008.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}